The economic burden of breast cancer in western Iran: a cross-sectional cost-of-illness study

Abstract Background Breast cancer is a significant global health challenge, affecting millions annually and imposing a considerable burden on healthcare systems and economies worldwide. This cross-sectional study aims to determine the economic impact of breast cancer in Lorestan Province, western Ir...

Full description

Saved in:
Bibliographic Details
Main Authors: Banafsheh Darvishi Teli, Meysam Behzadifar, Mania Beiranvand, Aziz Rezapour, Seyed Jafar Ehsanzadeh, Samad Azari, Ahad Bakhtiari, Payam Haghighatfard, Mariano Martini, Maryam Saran, Masoud Behzadifar
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Health, Population and Nutrition
Subjects:
Online Access:https://doi.org/10.1186/s41043-025-00738-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585677350371328
author Banafsheh Darvishi Teli
Meysam Behzadifar
Mania Beiranvand
Aziz Rezapour
Seyed Jafar Ehsanzadeh
Samad Azari
Ahad Bakhtiari
Payam Haghighatfard
Mariano Martini
Maryam Saran
Masoud Behzadifar
author_facet Banafsheh Darvishi Teli
Meysam Behzadifar
Mania Beiranvand
Aziz Rezapour
Seyed Jafar Ehsanzadeh
Samad Azari
Ahad Bakhtiari
Payam Haghighatfard
Mariano Martini
Maryam Saran
Masoud Behzadifar
author_sort Banafsheh Darvishi Teli
collection DOAJ
description Abstract Background Breast cancer is a significant global health challenge, affecting millions annually and imposing a considerable burden on healthcare systems and economies worldwide. This cross-sectional study aims to determine the economic impact of breast cancer in Lorestan Province, western Iran. Methods A retrospective cost-of-illness analysis utilizing a cross-sectional design was performed from November 2023 to July 2024. Data were collected using patient medical records and telephonic interviews. Costs were categorized into direct medical costs, direct non-medical costs, and indirect costs. A bottom-up approach was employed for cost calculation from a societal viewpoint, with a prevalence-based analysis. Results The study analyzed 525 patients with an average age of 42.74 ± 11.75 years. The total economic burden of breast cancer was estimated at $5,394,409.13, with a mean of $10,275.07 per patient. Direct medical costs comprised 70.2% of the total expenses, primarily attributed to hospitalization, chemotherapy, and laboratory tests. Direct non-medical costs, including accommodation and transportation for patients and their companions, accounted for 12.5%. Indirect costs, largely stemming from productivity losses due to morbidity and mortality, represented 17.3% of the total burden. Conclusion Breast cancer imposes a substantial economic burden on patients and their families in Lorestan Province. Enhancing health insurance coverage, providing government subsidies for treatment, and improving healthcare infrastructure to offer advanced diagnostic and treatment options locally are critical steps to alleviate this burden. Early detection and prevention programs can facilitate earlier diagnosis and reduce treatment costs. Comprehensive policies addressing both medical and non-medical expenses are necessary to improve patients’ quality of life and lessen the financial challenges associated with breast cancer in Iran.
format Article
id doaj-art-f1e5ddcfd2844bc792d51d9e75242d7f
institution Kabale University
issn 2072-1315
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Health, Population and Nutrition
spelling doaj-art-f1e5ddcfd2844bc792d51d9e75242d7f2025-01-26T12:39:17ZengBMCJournal of Health, Population and Nutrition2072-13152025-01-0144111110.1186/s41043-025-00738-0The economic burden of breast cancer in western Iran: a cross-sectional cost-of-illness studyBanafsheh Darvishi Teli0Meysam Behzadifar1Mania Beiranvand2Aziz Rezapour3Seyed Jafar Ehsanzadeh4Samad Azari5Ahad Bakhtiari6Payam Haghighatfard7Mariano Martini8Maryam Saran9Masoud Behzadifar10Health Management and Economics Research Center, School of Health Management and Information Sciences, University of Medical SciencesSocial Determinants of Health Research Center, Lorestan University of Medical SciencesDepartment of Surgery, School of Medicine, Lorestan University of Medical SciencesHealth Management and Economics Research Center, School of Health Management and Information Sciences, University of Medical SciencesEnglish Language Department, School of Health Management and Information Sciences, Iran University of Medical SciencesHospital Management Research Center, Health Management Research Institute, University of Medical SciencesHealth Equity Research Center (HERC), Tehran University of Medical Sciences (TUMS)Health Management and Economics Research Center, School of Health Management and Information Sciences, University of Medical SciencesDepartment of Health Sciences, University of GenoaSocial Determinants of Health Research Center, Lorestan University of Medical SciencesSocial Determinants of Health Research Center, Lorestan University of Medical SciencesAbstract Background Breast cancer is a significant global health challenge, affecting millions annually and imposing a considerable burden on healthcare systems and economies worldwide. This cross-sectional study aims to determine the economic impact of breast cancer in Lorestan Province, western Iran. Methods A retrospective cost-of-illness analysis utilizing a cross-sectional design was performed from November 2023 to July 2024. Data were collected using patient medical records and telephonic interviews. Costs were categorized into direct medical costs, direct non-medical costs, and indirect costs. A bottom-up approach was employed for cost calculation from a societal viewpoint, with a prevalence-based analysis. Results The study analyzed 525 patients with an average age of 42.74 ± 11.75 years. The total economic burden of breast cancer was estimated at $5,394,409.13, with a mean of $10,275.07 per patient. Direct medical costs comprised 70.2% of the total expenses, primarily attributed to hospitalization, chemotherapy, and laboratory tests. Direct non-medical costs, including accommodation and transportation for patients and their companions, accounted for 12.5%. Indirect costs, largely stemming from productivity losses due to morbidity and mortality, represented 17.3% of the total burden. Conclusion Breast cancer imposes a substantial economic burden on patients and their families in Lorestan Province. Enhancing health insurance coverage, providing government subsidies for treatment, and improving healthcare infrastructure to offer advanced diagnostic and treatment options locally are critical steps to alleviate this burden. Early detection and prevention programs can facilitate earlier diagnosis and reduce treatment costs. Comprehensive policies addressing both medical and non-medical expenses are necessary to improve patients’ quality of life and lessen the financial challenges associated with breast cancer in Iran.https://doi.org/10.1186/s41043-025-00738-0Breast cancerEconomic burdenCost of illnessHealth policyCross-sectional studyIran
spellingShingle Banafsheh Darvishi Teli
Meysam Behzadifar
Mania Beiranvand
Aziz Rezapour
Seyed Jafar Ehsanzadeh
Samad Azari
Ahad Bakhtiari
Payam Haghighatfard
Mariano Martini
Maryam Saran
Masoud Behzadifar
The economic burden of breast cancer in western Iran: a cross-sectional cost-of-illness study
Journal of Health, Population and Nutrition
Breast cancer
Economic burden
Cost of illness
Health policy
Cross-sectional study
Iran
title The economic burden of breast cancer in western Iran: a cross-sectional cost-of-illness study
title_full The economic burden of breast cancer in western Iran: a cross-sectional cost-of-illness study
title_fullStr The economic burden of breast cancer in western Iran: a cross-sectional cost-of-illness study
title_full_unstemmed The economic burden of breast cancer in western Iran: a cross-sectional cost-of-illness study
title_short The economic burden of breast cancer in western Iran: a cross-sectional cost-of-illness study
title_sort economic burden of breast cancer in western iran a cross sectional cost of illness study
topic Breast cancer
Economic burden
Cost of illness
Health policy
Cross-sectional study
Iran
url https://doi.org/10.1186/s41043-025-00738-0
work_keys_str_mv AT banafshehdarvishiteli theeconomicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT meysambehzadifar theeconomicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT maniabeiranvand theeconomicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT azizrezapour theeconomicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT seyedjafarehsanzadeh theeconomicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT samadazari theeconomicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT ahadbakhtiari theeconomicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT payamhaghighatfard theeconomicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT marianomartini theeconomicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT maryamsaran theeconomicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT masoudbehzadifar theeconomicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT banafshehdarvishiteli economicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT meysambehzadifar economicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT maniabeiranvand economicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT azizrezapour economicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT seyedjafarehsanzadeh economicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT samadazari economicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT ahadbakhtiari economicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT payamhaghighatfard economicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT marianomartini economicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT maryamsaran economicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy
AT masoudbehzadifar economicburdenofbreastcancerinwesterniranacrosssectionalcostofillnessstudy